185 related articles for article (PubMed ID: 28966327)
1. DPP4 Inhibition Ameliorates Cardiac Function by Blocking the Cleavage of HMGB1 in Diabetic Mice After Myocardial Infarction.
Sato A; Suzuki S; Watanabe S; Shimizu T; Nakamura Y; Misaka T; Yokokawa T; Shishido T; Saitoh SI; Ishida T; Kubota I; Takeishi Y
Int Heart J; 2017 Oct; 58(5):778-786. PubMed ID: 28966327
[TBL] [Abstract][Full Text] [Related]
2. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice.
Kitahara T; Takeishi Y; Harada M; Niizeki T; Suzuki S; Sasaki T; Ishino M; Bilim O; Nakajima O; Kubota I
Cardiovasc Res; 2008 Oct; 80(1):40-6. PubMed ID: 18558628
[TBL] [Abstract][Full Text] [Related]
3. Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice.
Sauvé M; Ban K; Momen MA; Zhou YQ; Henkelman RM; Husain M; Drucker DJ
Diabetes; 2010 Apr; 59(4):1063-73. PubMed ID: 20097729
[TBL] [Abstract][Full Text] [Related]
4. High Mobility Group Box 1 Promotes Angiogenesis from Bone Marrow-derived Endothelial Progenitor Cells after Myocardial Infarction.
Nakamura Y; Suzuki S; Shimizu T; Miyata M; Shishido T; Ikeda K; Saitoh S; Kubota I; Takeishi Y
J Atheroscler Thromb; 2015; 22(6):570-81. PubMed ID: 25735431
[TBL] [Abstract][Full Text] [Related]
5. Porphyromonas Gingivalis Elevated High-Mobility Group Box 1 Levels After Myocardial Infarction in Mice.
Srisuwantha R; Shiheido Y; Aoyama N; Sato H; Kure K; Laosrisin N; Izumi Y; Suzuki JI
Int Heart J; 2017 Oct; 58(5):762-768. PubMed ID: 28966323
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting DPP4 in a mouse model of HHT1 results in a shift towards regenerative macrophages and reduces fibrosis after myocardial infarction.
Dingenouts CKE; Bakker W; Lodder K; Wiesmeijer KC; Moerkamp AT; Maring JA; Arthur HM; Smits AM; Goumans MJ
PLoS One; 2017; 12(12):e0189805. PubMed ID: 29253907
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice.
Mulvihill EE; Varin EM; Ussher JR; Campbell JE; Bang KW; Abdullah T; Baggio LL; Drucker DJ
Diabetes; 2016 Mar; 65(3):742-54. PubMed ID: 26672095
[TBL] [Abstract][Full Text] [Related]
8. DPP-4 inhibition has beneficial effects on the heart after myocardial infarction.
Kubota A; Takano H; Wang H; Hasegawa H; Tadokoro H; Hirose M; Kobara Y; Yamada-Inagawa T; Komuro I; Kobayashi Y
J Mol Cell Cardiol; 2016 Feb; 91():72-80. PubMed ID: 26739213
[TBL] [Abstract][Full Text] [Related]
9. CHIP enhances angiogenesis and restores cardiac function after infarction in transgenic mice.
Xu CW; Zhang TP; Wang HX; Yang H; Li HH
Cell Physiol Biochem; 2013; 31(2-3):199-208. PubMed ID: 23485987
[TBL] [Abstract][Full Text] [Related]
10. Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction.
Apaijai N; Inthachai T; Lekawanvijit S; Chattipakorn SC; Chattipakorn N
J Endocrinol; 2016 Jun; 229(3):245-58. PubMed ID: 27044778
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of dipeptidyl peptidase-IV enzyme activity protects against myocardial ischemia-reperfusion injury in rats.
Chua S; Lee FY; Tsai TH; Sheu JJ; Leu S; Sun CK; Chen YL; Chang HW; Chai HT; Liu CF; Lu HI; Yip HK
J Transl Med; 2014 Dec; 12():357. PubMed ID: 25496837
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of PKCβ2 preserves cardiac function after myocardial infarction and is associated with improved angiogenesis of ischemic myocardium in diabetic rats.
Wang F; Huang D; Zhu W; Li S; Yan M; Wei M; Li J
Int J Mol Med; 2013 Nov; 32(5):1037-46. PubMed ID: 24002353
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of DPP-4 reduces acute mortality after myocardial infarction with restoration of autophagic response in type 2 diabetic rats.
Murase H; Kuno A; Miki T; Tanno M; Yano T; Kouzu H; Ishikawa S; Tobisawa T; Ogasawara M; Nishizawa K; Miura T
Cardiovasc Diabetol; 2015 Aug; 14():103. PubMed ID: 26259714
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl peptidase-4 inhibitors are associated with improved left ventricular diastolic function after acute myocardial infarction in diabetic patients.
Fujiwara T; Yoshida M; Nakamura T; Sakakura K; Wada H; Arao K; Katayama T; Funayama H; Sugawara Y; Mitsuhashi T; Kakei M; Momomura S; Ako J
Heart Vessels; 2015 Sep; 30(5):696-701. PubMed ID: 24736945
[TBL] [Abstract][Full Text] [Related]
15. Biological function of dipeptidyl peptidase-4 on type 2 diabetes patients and diabetic mice.
Qiao J; Li L; Ma Y; Shi R; Teng M
Curr Res Transl Med; 2019 Aug; 67(3):89-92. PubMed ID: 30591375
[TBL] [Abstract][Full Text] [Related]
16. Sitagliptin improves cardiac function after myocardial infarction through activation of autophagy in streptozotocin-induced diabetic mice.
Gu Y; Ma CT; Gu HL; Shi L; Tian XT; Xu WQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8973-8983. PubMed ID: 30575942
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of high-mobility group box 1 improves myocardial fibrosis and dysfunction in diabetic cardiomyopathy.
Wang WK; Wang B; Lu QH; Zhang W; Qin WD; Liu XJ; Liu XQ; An FS; Zhang Y; Zhang MX
Int J Cardiol; 2014 Mar; 172(1):202-12. PubMed ID: 24485636
[TBL] [Abstract][Full Text] [Related]
18. DPP-4 inhibition attenuates cardiac dysfunction and adverse remodeling following myocardial infarction in rats with experimental diabetes.
Connelly KA; Zhang Y; Advani A; Advani SL; Thai K; Yuen DA; Gilbert RE
Cardiovasc Ther; 2013 Oct; 31(5):259-67. PubMed ID: 22963483
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
[TBL] [Abstract][Full Text] [Related]
20. High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV.
Marchetti C; Di Carlo A; Facchiano F; Senatore C; De Cristofaro R; Luzi A; Federici M; Romani M; Napolitano M; Capogrossi MC; Germani A
Diabetologia; 2012 Jan; 55(1):236-44. PubMed ID: 21656024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
